274 related articles for article (PubMed ID: 18023711)
1. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
White RH; Chew H; Wun T
Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
4. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
5. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in ovarian cancer.
Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
[TBL] [Abstract][Full Text] [Related]
7. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
9. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
[TBL] [Abstract][Full Text] [Related]
10. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.
Raffini L; Huang YS; Witmer C; Feudtner C
Pediatrics; 2009 Oct; 124(4):1001-8. PubMed ID: 19736261
[TBL] [Abstract][Full Text] [Related]
11. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.
White RH; Chew HK; Zhou H; Parikh-Patel A; Harris D; Harvey D; Wun T
Arch Intern Med; 2005 Aug 8-22; 165(15):1782-7. PubMed ID: 16087828
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
Prandoni P; Samama MM
Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
[TBL] [Abstract][Full Text] [Related]
13. [Frequency of venous thromboembolism among hospitalized patients with cancer].
Conte G; Figueroa G
Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
15. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
16. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
17. A 10-year analysis of venous thromboembolism on the surgical service: the effect of practice guidelines for prophylaxis.
Shackford SR; Rogers FB; Terrien CM; Bouchard P; Ratliff J; Zubis R
Surgery; 2008 Jul; 144(1):3-11. PubMed ID: 18571579
[TBL] [Abstract][Full Text] [Related]
18. [Place of cancer among the risk factors in venous thromboembolism].
Descourt R; Righini M; Carrier M; Le Gal G
Pathol Biol (Paris); 2008 Jun; 56(4):178-83. PubMed ID: 18325691
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in cancer patients undergoing major surgery.
Osborne NH; Wakefield TW; Henke PK
Ann Surg Oncol; 2008 Dec; 15(12):3567-78. PubMed ID: 18841419
[TBL] [Abstract][Full Text] [Related]
20. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.
Duska LR; Garrett L; Henretta M; Ferriss JS; Lee L; Horowitz N
Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
